NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

CAMELLIA Cohort: A Longitudinal Study to Understand Sexual Health and Prevention Among Women in Alabama

Enrolling By InvitationNA

Sponsor: University of Alabama at Birmingham

Conditions: Hiv, Sexually Transmitted Diseases

Interventions: Camelia Cohort

Countries: United States

Pre-exposure prophylaxis (PrEP) is an important biomedical human immunodeficiency virus (HIV) prevention tool and may particularly benefit black, cis and trans-gender women, who are at an increased risk for HIV and Sexually Transmitted Infections (STIs). The purpose of this study is to use a population-based approach to create a cohort of cis and trans-gender women at risk for future HIV acquisition to better understand the factors associated with the risk of STIs and HIV diagnosis and predictors of PrEP use.

Eligibility overview

Sex: ALL

Age: 18 Years to 89 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Self identify as a Cis-gender or Trans-gender woman
* Age 18 - 89
* Reported STI in past 3 months by the Alabama Department of Public Health (ADPH)
* Gonorrhea and Syphilis negative
* HIV negative at screening encounter
* Live in Alabama
* Have access to a private smart phone

Exclusion Criteria:

* Live outside of Alabama
* Positive diagnosis for HIV, Gonorrhea, or Syphilis

Locations (1)

Birmingham, Alabama, United States